Brovana 15 mcg (arformoterol tartrate) Inhalation Solution

About COPD

Helpful Links & Downloads

Healthcare Provider Discussion Guide
Caregiver Checklist
Emergency Room Readiness

For information on how to be prepared for medical appointments, visit: http://www.ahrq.gov/qual/beprepared.htm

Reliable lung health information and sources for general information about chronic obstructive pulmonary disease (COPD):
Alpha-1 Foundation
American Academy of Family Physicians
American Association for Respiratory Care
American College of Clinical Pharmacy
American College of Physicians
American Lung Association
American Thoracic Society
COPD Foundation
COPD International
EFFORTS—Emphysema Foundation for Our Right to Survive
National Emphysema COPD Association
National Emphysema Foundation
National Heart, Lung, and Blood Institute
US National Library of Medicine and the National Institutes of Health
US National Library of Medicine and the National Institutes of Health - Medline Plus COPD Interactive Tutorial
World Health Organization
The Global Initiative for Chronic Obstructive Lung Disease - developed guidelines for diagnosis, treatment, management, and prevention of COPD. This site includes information for both patients and professionals.

For more information about the Lung Health Study, visit: www.biostat.umn.edu/lhs

Resources to help smokers quit are available at:
www.smokefree.gov
health.yahoo.com/topic/smoking

BROVANA is a medicine called a long-acting beta₂-agonist or LABA. BROVANA is used long term, twice a day (morning and evening), in controlling symptoms of chronic obstructive pulmonary disease (COPD) in adults with COPD. BROVANA is for inhalation use only through a standard jet nebulizer connected to an air compressor and should not be swallowed or injected. BROVANA should not be used in children.

BROVANA IMPORTANT PATIENT INFORMATION

In patients with asthma, LABA medicines such as BROVANA may increase the chance of asthma-related death from asthma problems. It is not known if LABA medicines, such as BROVANA, increase the chance of death in patients with COPD. BROVANA does not relieve sudden symptoms of COPD and should not be used more than twice a day. Always have a short-acting beta₂-agonist with you to treat sudden symptoms. Get emergency medical care if breathing problems worsen quickly or you use you short-acting beta₂-agonist medicine but it does not relieve your breathing problems. Do not stop using BROVANA unless told to do so by your healthcare provider because your symptoms might get worse. When you are using BROVANA twice a day, do not use other medicines that contain a LABA for any reason.

Tell your doctor if you have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate or changes in heart rhythm. In COPD clinical trials, the most common adverse events reported with BROVANA were pain, chest pain, back pain, diarrhea, and sinusitis. Other possible side effects include headache, tremor, nervousness, and dizziness.

For additional information, please see the Complete Prescribing Information and Medication Guide for BROVANA (arformoterol tartrate) Inhalation Solution.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider.

All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient. BROVANA is a medicine used to treat COPD. Remember that no medicine is for everyone. Only your doctor can prescribe BROVANA for you.

Brovana 15mcg (arfermoterol tartrate) Inhalation Solution

About COPD

Helpful Links & Downloads

BROVANA IMPORTANT PATIENT INFORMATION